AJP - Regu Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 275: R1256-R1264, 1998;
0363-6119/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buga, G. M.
Right arrow Articles by Ignarro, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buga, G. M.
Right arrow Articles by Ignarro, L. J.
Vol. 275, Issue 4, R1256-R1264, October 1998

NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms

Georgette M. Buga, Liu Hua Wei, Philip M. Bauer, Jon M. Fukuto, and Louis J. Ignarro

Department of Molecular and Medical Pharmacology, University of California Los Angeles School of Medicine, Los Angeles, California 90095-1735

The objective of this study was to elucidate the role and mechanism of nitric oxide (NO) synthase (NOS) in modulating the growth of the Caco-2 human colon carcinoma cell line. The two novel observations reported here are, first, that NG-hydroxy-L-arginine (NOHA) inhibits Caco-2 tumor cell proliferation, likely by inhibiting arginase activity, and, second, that NO causes cytostasis by mechanisms that might involve inhibition of ornithine decarboxylase (ODC) activity. Both arginase and ODC are enzymes involved in the conversion of arginine to polyamines required for cell proliferation. Cell growth was monitored by cell count, cell protein analysis, and DNA synthesis. NOHA (1-30 µM) and NO in the form of DETA/NO (1-30 µM) inhibited cell proliferation by 30-85%. The cytostatic effect of NOHA was prevented by addition of excess ornithine, putrescine, spermidine, or spermine to cell cultures, whereas the cytostatic effect of NO (DETA/NO) and alpha -difluoromethylornithine (ODC inhibitor) was unaffected by ornithine but was prevented by putrescine, spermidine, or spermine. The cytostatic effect of NOHA appeared to be independent of its conversion to NO, and the effect of NO appeared to be independent of cGMP. NOHA inhibited urea production by Caco-2 cells and inhibited arginase catalytic activity (85% at 3 µM), whereas NO (DEA/NO and SNAP) inhibited ODC activity (>= 60% at 30 µM) without affecting arginase activity. Coculture of Caco-2 cells with lipopolysaccharide/cytokine-activated rat aortic endothelial cells markedly slowed Caco-2 cell proliferation, and this was blocked by NOS inhibitors. These observations that NOHA and NO may inhibit sequential steps in the arginine-polyamine pathway suggest a novel biological role for NOS in the inhibition of cell proliferation of certain tumor cells and possibly other cell types.

arginase induction and inhibition; ornithine decarboxylase inhibition; polyamines; tumor cytostasis; vascular endothelial cells


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
L. H. Wei, Y. Yang, G. Wu, and L. J. Ignarro
IL-4 and IL-13 upregulate ornithine decarboxylase expression by PI3K and MAP kinase pathways in vascular smooth muscle cells
Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1198 - C1205.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. S. Goligorsky
Endothelial cell dysfunction: can't live with it, how to live without it
Am J Physiol Renal Physiol, May 1, 2005; 288(5): F871 - F880.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Singh, S. Pervin, and G. Chaudhuri
Caspase-8-mediated BID Cleavage and Release of Mitochondrial Cytochrome c during Nomega -Hydroxy-L-arginine-induced Apoptosis in MDA-MB-468 Cells. ANTAGONISTIC EFFECTS OF L-ORNITHINE
J. Biol. Chem., September 27, 2002; 277(40): 37630 - 37636.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Li, C. J. Meininger, K. A. Kelly, J. R. Hawker Jr., S. M. Morris Jr., and G. Wu
Activities of arginase I and II are limiting for endothelial cell proliferation
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R64 - R69.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. T. Jacobs and L. J. Ignarro
Lipopolysaccharide-induced Expression of Interferon-beta Mediates the Timing of Inducible Nitric-oxide Synthase Induction in RAW 264.7 Macrophages
J. Biol. Chem., December 14, 2001; 276(51): 47950 - 47957.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Kepka-Lenhart, S. K. Mistry, G. Wu, and S. M. Morris Jr.
Arginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages?
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2237 - R2242.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
L. H. Wei, A. T. Jacobs, S. M. Morris Jr., and L. J. Ignarro
IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells
Am J Physiol Cell Physiol, July 1, 2000; 279(1): C248 - C256.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Singh, S. Pervin, A. Karimi, S. Cederbaum, and G. Chaudhuri
Arginase Activity in Human Breast Cancer Cell Lines: N{{omega}}-Hydroxy-L-arginine Selectively Inhibits Cell Proliferation and Induces Apoptosis in MDA-MB-468 Cells
Cancer Res., June 1, 2000; 60(12): 3305 - 3312.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
S. Kim and P. Ponka
Effects of Interferon-gamma and Lipopolysaccharide on Macrophage Iron Metabolism Are Mediated by Nitric Oxide-induced Degradation of Iron Regulatory Protein 2
J. Biol. Chem., February 25, 2000; 275(9): 6220 - 6226.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
J. B. Mannick, A. Hausladen, L. Liu, D. T. Hess, M. Zeng, Q. X. Miao, L. S. Kane, A. J. Gow, and J. S. Stamler
Fas-Induced Caspase Denitrosylation
Science, April 23, 1999; 284(5414): 651 - 654.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
P. M. Bauer, G. M. Buga, J. M. Fukuto, A. E. Pegg, and L. J. Ignarro
Nitric Oxide Inhibits Ornithine Decarboxylase via S-Nitrosylation of Cysteine 360 in the Active Site of the Enzyme
J. Biol. Chem., September 7, 2001; 276(37): 34458 - 34464.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. J. Ignarro, G. M. Buga, L. H. Wei, P. M. Bauer, G. Wu, and P. del Soldato
Inaugural Article: Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation
PNAS, March 27, 2001; 98(7): 4202 - 4208.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. H. Wei, G. Wu, S. M. Morris Jr., and L. J. Ignarro
Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation
PNAS, July 31, 2001; 98(16): 9260 - 9264.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. M. Bauer, G. M. Buga, and L. J. Ignarro
Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide
PNAS, October 23, 2001; 98(22): 12802 - 12807.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online